SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

BRIEF-Timber Pharmaceuticals' Development Partner, Aft Pharmaceuticals, Enter Licensing Agreement For Pascomer In Europe

· 03/17/2021 08:08
BRIEF-Timber Pharmaceuticals' Development Partner, Aft Pharmaceuticals, Enter Licensing Agreement For Pascomer In Europe

- Timber Pharmaceuticals Inc TMBR.A:

  • TIMBER PHARMACEUTICALS’ DEVELOPMENT PARTNER, AFT PHARMACEUTICALS, ENTERS INTO LICENSING AGREEMENT FOR PASCOMER® (TMB-002) IN EUROPE

  • TIMBER - EXTENSION OF AGREEMENT WITH AFT PHARMACEUTICALS GRANTS DESITIN ARZNEIMITTEL GMBH EXCLUSIVE LICENSE, SUPPLY RIGHTS FOR TMB-002 IN EUROPE

Source text for Eikon: ID:nGNX2kWFWp

Further company coverage: TMBR.A


((Reuters.Briefs@thomsonreuters.com;))